Literature DB >> 30715978

Improving The Medicare Physician Fee Schedule: Make It Part Of Value-Based Payment.

Robert A Berenson1, Paul B Ginsburg2.   

Abstract

Alternative Payment Models (APMs) can address the limitations inherent in fee-for-service payment to support new approaches to health care delivery that produce greater value. But the models being tested are directly layered on top of fee-for-service architecture, specifically the Medicare Physician Fee Schedule. Shoring up that architecture to produce greater value, in combination with APMs, should be considered an integral part of the movement to value-based payment. We propose ending the split within the Centers for Medicare and Medicaid Services between the people managing the Medicare Physician Fee Schedule and those creating and testing APMs, with both groups advised by a revamped Physician-Focused Payment Model Technical Advisory Committee that covers both dimensions of creating greater value.

Entities:  

Mesh:

Year:  2019        PMID: 30715978     DOI: 10.1377/hlthaff.2018.05411

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  5 in total

1.  Fee-for-service payment is not the (main) problem.

Authors:  Bryan E Dowd; Miriam J Laugesen
Journal:  Health Serv Res       Date:  2020-08       Impact factor: 3.402

2.  Commentary: It's more than just the price.

Authors:  Harold S Luft
Journal:  Health Serv Res       Date:  2020-08       Impact factor: 3.402

3.  Differences in the Complexity of Office Visits by Physician Specialty: NAMCS 2013-2016.

Authors:  John D Goodson; Sara Shahbazi; Karthik Rao; Zirui Song
Journal:  J Gen Intern Med       Date:  2020-03-10       Impact factor: 5.128

4.  Emergency Physician Reimbursement: Getting Shortchanged or Shrewdly Negotiating?

Authors:  Arjun K Venkatesh; Alexander T Janke
Journal:  Ann Emerg Med       Date:  2020-11       Impact factor: 6.762

5.  Taking account of accountable care.

Authors:  Zirui Song
Journal:  Health Serv Res       Date:  2021-06-08       Impact factor: 3.734

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.